CRISPR/Cas9 genome editing in human hematopoietic stem cells.

Bak, Rasmus O, Dever, Daniel P, Porteus, Matthew H·2018·Nature Protocols
DOI 10.1038/nprot.2017.143

Cited by (317)

Items 301–317 of 317

  1. Distinct and convergent effects of SF3B1 mutations in human breast cancer
    Riley E. Bergman, Christin I. Keeton, Irika R. Sinha, Jonathan P. Ling, Yu Wang, Lauren Ha, Eshani P. Mehta, Sarah C. Reed, Ethan K. Fox, Tina M. O’Grady et al. · 2025 · Proceedings of the National Academy of Sciences
  2. Site-specific Integration of Therapeutic-length Genes using TIVID System
    Xiao‐Bing Zhang, Zhu-Ying Gao, Tian-Lai Shen, Chong-Ya Cheng, Yu-Meng Zhang, Li-Ming Zhang, Xi-Die Zhao, Jianping Zhang · 2025 · Research Square
  3. Additional file 1 of Efficient delivery of a large-size Cas9-EGFP vector in porcine fetal fibroblasts using a Lonza 4D-Nucleofector system
    Liu, Weiwei, Wang, Xiaoguo, Liu, Ruirong, Liao, Yaya, Peng, Zhiwei, Jiang, Haoyun, Jing, Qiqi, 幸宇云 · 2023 · Figshare
  4. Additional file 1 of YAP and TAZ play a crucial role in human erythrocyte maturation and enucleation
    Nattaya Damkham, Chanchao Lorthongpanich, Phatchanat Klaihmon, Usaneeporn Lueangamornnara, Pakpoom Kheolamai, Kongtana Trakarnsanga, Surapol Issaragrisil · 2022 · Figshare
  5. Gene Therapy for Inborn Errors of Immunity
    Soraia P. Caetano-Silva, Claire Booth · 2025 · Wiley eBooks
  6. Cholesterol Biosynthesis is a Targetable Vulnerability of CEBPA -mutant Acute Myeloid Leukemia
    Sofie Ulfbeck Schovsbo, Yang Liu, Pedro Aragon-Fernandez, Sandra Leigh Gordon, Mikkel Bruhn Schuster, Jinyu Su, Sachin Pundhir, Nanna S. Mikkelsen, Erwin M. Schoof, Kim Theilgaard‐Mönch et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  7. A Dual-Viral Delivery Platform Enables Efficient Site-Specific Integration of Therapeutic-Length Genes in Human Primary Stem Cells
    Zhu-Ying Gao, Tian-Lai Shen, Chong-Yan Cheng, Yuanhao Sun, Liming Zhang, Jian-Ping Zhang, Xiao-Bing Zhang · 2026 · Human Gene Therapy
  8. CRISPR/Cas9 gene editing in hematopoietic stem and progenitor cells to accelerate the translation of cellular therapies and immunotherapies
    Laura Falceto Font, Dan Jin, John Figg, Connor P. Francis, Kaytora Long-James, Jeffrey Drake, Alexandra Reid, Caitland Love, Brianna McDonald, David Hilferty et al. · 2026 · Journal of Translational Research
  9. Editing around the target: epitope engineering to protect stem cell grafts
    Joanne Seoyoung Baek, Gabriele Casirati, Pietro Genovese, Saar I. Gill · 2026 · Blood Advances
  10. CRISPR integration of an FLT3 CAR into the TRAC locus generates CAR T cells for AML
    Maya Graham Noer, Kimmie B. Christensen, Nanna S. Mikkelsen, Sigrid Fu Skjelbostad, Frederik Holm Rothemejer, Thomas Rea Wittenborn, Simon Fammé, Kasper Mikkelsen, Torben Barington, Martin Kristian Thomsen et al. · 2026 · Genome Medicine
  11. Glycosylation orchestrates megakaryocytic fate of hematopoietic stem cells via Wnt-MUC13 signaling
    Alejandro Roisman, Leonardo Rivadeneyra, Lindsey R. Conroy, Natalia Weich, Agata Steenackers, Melissa M. Lee‐Sundlov, Simon H. Glabere, Shikan Zheng, Katelyn E. Rosenbalm, Mark Zogg et al. · 2026 · Nature Communications
  12. Therapeutic CRISPR/Cas9 delivery approaches: strengths, limitations, and a roadmap for clinical translation
    Maryam Rezaee, Farideh Izadi, Saeed Nobaharian, Leila Hassani, Esmaeil Rezaei, Sara Sadeghi Amini, Ali Akbar Pourfathollah, Ali Kowsari, Sirous Naeimi, Khalil Khashei Varnamkhasti et al. · 2026 · Beni-Suef University Journal of Basic and Applied Sciences
  13. SLC25A38 gene modification mediated by CRISPR/Cas9 in HEK293T cell line
    Shokoufeh Yazdanparast, Hamid Galehdari, S.R. Khatami, Elham Hoveizi · 2026 · Journal of Applied Genetics
  14. Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective
    Rajath Samaga, Udisha Singh, Sachin Dattram Pawar · 2026 · Biotechnology and Bioengineering
  15. Cell surface CD11c as a neutrophil aging marker molecule
    Sophia Koutsogiannaki, Fahd Alhamdan, Erik Malm, Marie Bermudez, Samuel Y. Kim, Koichi Yuki · 2026 · FEBS Open Bio
  16. CRISPR‐Cas9 and precision editing technologies linking functional genomics to clinical translation in genetic diseases
    Zijing Wen, Jianming Su · 2026 · Clinical and Translational Medicine
  17. Prime editing of human hematopoietic stem cells for correction of GATA2 deficiency
    Jonas Holst Wolff, Thomas Wisbech Skov, Sofie Rahbek Dorset, Janni Sjelborg, Sujan Ravendran, Anne Louise Revenfeld, Didde Haslund, Anaïs Marie Julie Møller, Mette Holm, Martin Kristian Thomsen et al. · 2026 · Science Translational Medicine